Ligand Pharmaceuticals (LGND) Free Cash Flow (2010 - 2026)
Ligand Pharmaceuticals (LGND) free cash flow from Jun 30, 2010 to Mar 31, 2026. The TTM Ligand Pharmaceuticals (LGND) free cash flow is $123M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Ligand Pharmaceuticals (LGND) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +141.52% |
| 3 Years TTM | +5.65% |
| 5 Years TTM | +22.85% |
| 10 Years TTM | +10.12% |
Annual Free Cash Flow change of Ligand Pharmaceuticals (LGND)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $48M | -0.92% |
| 2025 | $49M | -48.64% |
| 2024 | $95M | +106.75% |
| 2023 | $46M | -61.59% |
| 2022 | $120M | +71.23% |
| 2021 | $70M | +39.72% |
| 2020 | $50M | -257.20% |
| 2019 | -$32M | -116.51% |
| 2018 | $193M | +111.32% |
| 2017 | $91M | +49.48% |
| 2016 | $61M | +46.85% |
| 2015 | $42M | +105.02% |
| 2014 | $20M | N/A |
| 2013 | $20M | -4715.91% |
| 2012 | -$440K | -64.80% |
| 2011 | -$1.25M | -95.39% |
| 2010 | -$27M | -20.92% |
| 2009 | -$34M | N/A |
Comparison Ligand Pharmaceuticals (LGND) five years free cash flow CAGR with competitors
Ligand Pharmaceuticals (LGND) five years free cash flow CAGR is 22.85%.